keyword
https://read.qxmd.com/read/38621719/rituximab-or-cyclosporine-a-for-the-treatment-of-membranous-nephropathy-economic-evaluation-of-the-mentor-trial
#21
JOURNAL ARTICLE
Matthew Kadatz, Scott Klarenbach, Helen So, Fernando C Fervenza, Daniel C Cattran, Sean J Barbour
BACKGROUND AND HYPOTHESIS: The MENTOR trial (MEmbranous Nephropathy Trial Of Rituximab) showed that rituximab was noninferior to cyclosporine in inducing complete or partial remission of proteinuria and was superior in maintaining proteinuria remission. However, the cost of rituximab may prohibit first-line use for some patients and health care payers. METHODS: A Markov model was used to determine the incremental cost-effectiveness ratio (ICER) of rituximab compared with cyclosporine for the treatment membranous nephropathy from the perspective of a health care payer with a life-time time horizon...
April 15, 2024: Nephrology, Dialysis, Transplantation
https://read.qxmd.com/read/38621685/-cardiac-rehabilitation-after-acute-coronary-syndrome
#22
JOURNAL ARTICLE
Axel Schlitt
Cardiac rehabilitation is a fundamental part of treatment after acute coronary syndrome and should be followed within the first 14 days of the acute inpatient stay. The prognostic value in terms of improving quality of life, reducing both re-hospitalizations and cardiovascular mortality has been shown in numerous studies in recent years. The multimodal, interdisciplinary cardiac rehabilitation aims to maintain and restore the patients' ability to cope with everyday life. The characteristic of cardiac rehabilitation is the combination of sports and physiotherapy, psychosocial care, nutritional therapy, medical diagnostics, and therapy adjustment as well as aftercare recommendations within the framework of a 3-4 week stay in specialized rehabilitation facilities...
April 2024: Deutsche Medizinische Wochenschrift
https://read.qxmd.com/read/38621548/cost-effectiveness-analysis-of-fluticasone-furoate-umeclidinium-bromide-vilanterol-and-umeclidinium-bromide-vilanterol-in-the-management-of-moderate-and-severe-copd-in-china
#23
JOURNAL ARTICLE
Yuan Zhou, Shujing Duan, Lei Zhang, Fangchen Peng
OBJECTIVE: A study has analyzed the long-term cost-effectiveness of fluticasone furoate/umeclidinium bromide/vilanterol combination therapy (FF/UMEC/VI) versus umeclidinium bromide/vilanterol dual therapy (UMEC/VI) in the treatment of moderate or severe chronic obstructive pulmonary disease (COPD), providing evidence for decision-making in COPD treatment. METHODS: From the perspective of the whole society, a Markov model based on the severity of COPD was established, consisting of four states: moderate, severe, very severe, and death ...
April 13, 2024: Respiratory Medicine
https://read.qxmd.com/read/38621481/cost-effectiveness-of-brca1-testing-at-time-of-obstetrical-prenatal-carrier-screening-for-cancer-prevention
#24
JOURNAL ARTICLE
Shayan M Dioun, Luiza R Perez, Malavika Prabhu, Jesse T Brewer, Muhammad D Ahsan, June Y Hou, Ravi N Sharaf, Jason D Wright, Melissa K Frey
BACKGROUND: Improved technologies paired with an increase in access to genetic testing has led to the availability of expanded carrier screening evaluating hundreds of disorders. Currently, most autosomal dominant mutations, such as BRCA1, are not included in expanded carrier assays. Screening pregnant or preconception reproductive-aged women for BRCA1 may present a unique opportunity to perform population-based screening for patients at a time where precancer screening, chemoprevention and/or risk reducing surgery may be beneficial...
April 13, 2024: American Journal of Obstetrics and Gynecology
https://read.qxmd.com/read/38621441/association-of-psychosocial-risk-factors-with-quality-of-life-and-readmissions-1-year-after-lvad-implantation
#25
JOURNAL ARTICLE
Jeffrey Wang, Alexis K Okoh, Yuxuan Chen, Rebecca S Steinberg, Apoorva Gangavelli, Krishan J Patel, Yi-An Ko, Jeffrey D Alexis, Shivani A Patel, David J Vega, Mani Daneshmand, Ersilia M DeFilippis, Khadijah Breathett, Alanna A Morris
BACKGROUND: Among patients with advanced heart failure (HF), treatment with a left ventricular assist device (LVAD) improves health-related quality of life (HRQOL). We investigated the association between psychosocial risk factors, HRQOL, and outcomes after LVAD implantation. METHODS: A retrospective cohort (n=9832) of adults aged ≥ 19 years who received durable LVAD between 2008 - 2017 was identified using the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS)...
April 13, 2024: Journal of Cardiac Failure
https://read.qxmd.com/read/38619865/developing-a-multiprofessional-mobile-app-to-enhance-health-habits-in-older-adults-user-centered-approach
#26
JOURNAL ARTICLE
Andressa Crystine da Silva Sobrinho, Grace Angelica de Oliveira Gomes, Carlos Roberto Bueno Júnior
BACKGROUND: Although comprehensive lifestyle habits are crucial for healthy aging, their adherence tends to decline as individuals grow older. Sustaining a healthy life over time poses a motivational challenge. Some digital tools, such as smartphone apps aimed at promoting healthy habits, have been used to counteract this decline. However, a more profound investigation is necessary into the diverse experiences of users, particularly when it concerns older adults or those who are unfamiliar with information and communications technologies...
April 15, 2024: JMIR Formative Research
https://read.qxmd.com/read/38619802/cost-utility-analysis-of-vericiguat-in-heart-failure-with-reduced-ejection-fraction-after-worsening-heart-failure-events-in-china
#27
JOURNAL ARTICLE
Penglei Chen, Yixiang Wang, Xin Liu, Jiaqi Yu, Xuwei Zheng
OBJECTIVE: Vericiguat is a new medication to demonstrate clinical efficacy in heart failure with reduced ejection fraction (HFrEF) after worsening heart failure (WHF) events, but its cost-utility was unknown. We aimed to assess the cost-utility of combining the application of vericiguat with standard treatment in HFrEF patients who had WHF events. METHODS: A multistate Markov model was implemented to mimic the economic results of HFrEF patients who had WHF events in China after receiving vericiguat or placebo...
April 15, 2024: American Journal of Cardiovascular Drugs: Drugs, Devices, and Other Interventions
https://read.qxmd.com/read/38618500/capacity-for-the-management-of-kidney-failure-in-the-international-society-of-nephrology-latin-america-region-report-from-the-2023-isn-global-kidney-health-atlas-isn-gkha
#28
REVIEW
Viviane Calice-Silva, Javier A Neyra, Alejandro Ferreiro Fuentes, Krissia Kamile Singer Wallbach Massai, Silvia Arruebo, Aminu K Bello, Fergus J Caskey, Sandrine Damster, Jo-Ann Donner, Vivekanand Jha, David W Johnson, Adeera Levin, Charu Malik, Masaomi Nangaku, Ikechi G Okpechi, Marcello Tonelli, Feng Ye, Magdalena Madero, Carmen Tzanno Martins
Successful management of chronic kidney disease (CKD) in Latin America (LA) continues to represent a challenge due to high disease burden and geographic disparities and difficulties in terms of capacity, accessibility, equity, and quality of kidney failure care. Although LA has experienced significant social and economic progress over the past decades, there are still important inequities in health care access. Through this third iteration of the International Society of Nephrology Global Kidney Health Atlas, the indicators regarding kidney failure care in LA are updated...
April 2024: Kidney International Supplements
https://read.qxmd.com/read/38618473/oral-health-related-quality-of-life-among-non-institutionalized-elderly-in-malaysia-a-teaching-hospital-based-survey
#29
JOURNAL ARTICLE
Avenia Shammah Ramien, Amirul Arif Bin Azmi, Sethu Ravichandran, Trisha Thein Wai Li, Sashmeetavani Ravendran, Htoo Htoo Kyaw Soe, Ramanathan Ravi, Harini Priya, Silpa Madhuri Chikkala, Renjith George Pallivathukal
Background In Malaysia, the Geriatric Oral Health Assessment Index (GOHAI) has been recognized as a vital instrument for evaluating oral health-related quality of life among the elderly population. Its integration into the National Health and Morbidity Survey (NHMS) in 2018 demonstrates the country's dedication to understanding and addressing the unique oral health challenges faced by older individuals. The NHMS, led by the Ministry of Health Malaysia, serves as a crucial platform for identifying and addressing healthcare needs, while also working towards achieving sustainable development goals...
March 2024: Curēus
https://read.qxmd.com/read/38618379/unveiling-the-chameleon-a-case-report-on-acute-intermittent-porphyria
#30
Manish Shrestha, Shefali Amin, Christopher Reggio, Arpan Pokhrel, Salina Munankami, Jakob Nypaver, Riju Gupta, Anthony Donato
Acute intermittent porphyria (AIP) is a rare autosomal dominant metabolic disorder with low penetrance, often presenting with a broad spectrum of clinical manifestations. Acute neurovisceral attacks commonly occur in young women, mimicking signs and symptoms of other medical and psychiatric conditions, thus delaying the diagnosis. We present the case of an 18-year-old female college student with recurrent hospitalizations for intractable abdominal pain, now again with pain and new subjective hematuria. The patient had previously undergone an endoscopy/colonoscopy with negative biopsies and serologies for acute pathology, including celiac disease...
March 2024: Curēus
https://read.qxmd.com/read/38618213/the-impact-of-frailty-on-surgical-outcome-of-patients-with-lumbar-spinal-canal-stenosis
#31
JOURNAL ARTICLE
Saiki Sugimoto, Sota Nagai, Kei Ito, Hiroki Takeda, Soya Kawabata, Takehiro Michikawa, Daiki Ikeda, Shinjiro Kaneko, Nobuyuki Fujita
INTRODUCTION: Frailty is an important factor in surgical outcomes. The current study aimed to evaluate the effect of preoperative frailty on postoperative outcomes in older patients with lumbar spinal canal stenosis (LSCS). METHODS: We retrospectively examined 209 patients aged ≥65 years who underwent surgery for LSCS. Health-related quality-of-life (HRQOL) tools, including the Roland-Morris Disability Questionnaire (RDQ), Zurich Claudication Questionnaire (ZCQ), and Japanese Orthopaedic Association Back Pain Evaluation Questionnaire (JOABPEQ), were used in the assessment conducted before surgery and at 6 months and 1 year after surgery...
March 27, 2024: Spine surgery and related research
https://read.qxmd.com/read/38617555/caregiver-experiences-and-burden-in-moderate-advanced-dementia-with-lewy-bodies
#32
JOURNAL ARTICLE
Melissa J Armstrong, Yunfeng Dai, Kaitlin Sovich, Brian LaBarre, Henry L Paulson, Susan M Maixner, Julie A Fields, Angela M Lunde, Leah K Forsberg, Bradley F Boeve, Carol A Manning, James E Galvin, Angela S Taylor, Zhigang Li
BACKGROUND AND OBJECTIVES: Dementia with Lewy bodies (DLB) is a common degenerative dementia, but research on caregiver experiences in late stages is lacking. This study aimed to investigate the caregiving experience in moderate-advanced DLB to identify opportunities for improving care and support. METHODS: Dyads of individuals with moderate-advanced DLB and their primary informal caregivers were recruited from specialty clinics, advocacy organizations, and research registries...
June 2024: Neurology. Clinical Practice
https://read.qxmd.com/read/38616317/the-burden-of-occupational-noise-induced-hearing-loss-from-1990-to-2019-an-analysis-of-global-burden-of-disease-data
#33
JOURNAL ARTICLE
Ce Liu, Li He, Xiaobing Shan, Ling Zhang, Erjia Ge, Kai Zhang, Bin Luo
OBJECTIVES: The relationship between long-term exposure to occupational noise and hearing loss has been extensively documented. We aimed to assess spatial and temporal changes in the burden of occupational noise-induced hearing loss (ONIHL) in 204 countries and territories with varying socio-demographic indexes (SDI) from 1990 to 2019. DESIGN: Temporal and spatial trends in age-standardized disability-adjusted life year rates (ASDR) for ONIHL were estimated by sex, age, SDI level, country, and geographic region from 1990 to 2019...
April 15, 2024: Ear and Hearing
https://read.qxmd.com/read/38615282/cost-utility-analysis-of-using-high-intensity-statin-among-post-hospitalized-acute-coronary-syndrome-patients
#34
JOURNAL ARTICLE
Pramitha Esha Nirmala Dewi, Montarat Thavorncharoensap, Bangunawati Rahajeng
BACKGROUND: Post-hospitalized acute coronary syndrome (ACS) patients in Indonesia National Insurance does not pay for the use of high-intensity statin (HIS) for secondary prevention after ACS hospitalization. Moreover, a cost-utility analysis needs to be conducted to evaluate the cost-effectiveness of prescribing HIS and low-to-moderate-intensity statin (LMIS) per quality-adjusted life year (QALY). This study aimed to estimate the cost-utility of long-term HIS treatment in post-hospitalized ACS patients in Indonesia compared to current practice...
April 14, 2024: Egyptian Heart Journal: EHJ
https://read.qxmd.com/read/38615050/health-economic-evaluation-of-blended-collaborative-care-for-older-multimorbid-heart-failure-patients-study-protocol
#35
JOURNAL ARTICLE
Lisa Derendorf, Stephanie Stock, Dusan Simic, Arim Shukri, Christine Zelenak, Jonas Nagel, Tim Friede, Birgit Herbeck Belnap, Christoph Herrmann-Lingen, Susanne S Pedersen, Jan Sørensen, Dirk Müller And On Behalf Of The Escape Consortium
BACKGROUND: Integrated care, in particular the 'Blended Collaborative Care (BCC)' strategy, may have the potential to improve health-related quality of life (HRQoL) in multimorbid patients with heart failure (HF) and psychosocial burden at no or low additional cost. The ESCAPE trial is a randomised controlled trial for the evaluation of a BCC approach in five European countries. For the economic evaluation of alongside this trial, the four main objectives were: (i) to document the costs of delivering the intervention, (ii) to assess the running costs across study sites, (iii) to evaluate short-term cost-effectiveness and cost-utility compared to providers' usual care, and (iv) to examine the budgetary implications...
April 13, 2024: Cost Effectiveness and Resource Allocation: C/E
https://read.qxmd.com/read/38614935/-cost-effectiveness-analysis-of-fracture-liaison-services-in-catalonia
#36
JOURNAL ARTICLE
X Surís, M J Pueyo-Sánchez, A Ricart, A Naranjo, T Casanova, C Gómez-Vaquero, E Duaso, J M Cancio-Trujillo, J Sánchez-Martín, A Pérez-Mitru
OBJECTIVE: To assess the cost-effectiveness of Fracture Liaison Service (FLS) compared to the standard of care for secondary prevention of fragility fractures form the perspective of the Catalan Health Service. METHODS: Cost-utility assessment through a Markov model that simulated disease progression of a patients' cohort candidates to initiate antiosteoporotic treatment after a fragility fracture. A time horizon of 10 years and a 6-month duration per cycle was established...
April 12, 2024: Journal of Healthcare Quality Research
https://read.qxmd.com/read/38611036/utility-scores-for-risk-reducing-mastectomy-and-risk-reducing-salpingo-oophorectomy-mapping-to-eq-5d
#37
JOURNAL ARTICLE
Samuel G Oxley, Xia Wei, Michail Sideris, Oleg Blyuss, Ashwin Kalra, Jacqueline J Y Sia, Subhasheenee Ganesan, Caitlin T Fierheller, Li Sun, Zia Sadique, Haomiao Jin, Ranjit Manchanda, Rosa Legood
BACKGROUND: Risk-reducing mastectomy (RRM) and risk-reducing salpingo-oophorectomy (RRSO) are the most effective breast and ovarian cancer preventive interventions. EQ-5D is the recommended tool to assess the quality of life and determine health-related utility scores (HRUSs), yet there are no published EQ-5D HRUSs after these procedures. These are essential for clinicians counselling patients and for health-economic evaluations. METHODS: We used aggregate data from our published systematic review and converted SF-36/SF-12 summary scores to EQ-5D HRUSs using a published mapping algorithm...
March 30, 2024: Cancers
https://read.qxmd.com/read/38610983/distinct-prostate-cancer-survival-outcomes-in-firefighters-a-population-based-study
#38
JOURNAL ARTICLE
Paulo S Pinheiro, Tulay Koru-Sengul, Wei Zhao, Diana R Hernandez, Monique N Hernandez, Erin N Kobetz, Alberto J Caban-Martinez, David J Lee
Introduction: Survival outcomes for prostate cancer among specific occupational groups prone to regular medical check-ups vis-à-vis the general population have been understudied. For firefighters, a demographic subject to rigorous medical evaluations, possessing above-average medical expertise, and exposed to specific carcinogens of interest, prostate cancer survival in the US has never been studied. Methods: We conducted a retrospective study, utilizing data from the Florida Cancer Data System spanning 2004 to 2014, coupled with firefighter certification records from the Florida State Fire Marshal's Office...
March 27, 2024: Cancers
https://read.qxmd.com/read/38610958/patient-relevant-costs-for-organ-preservation-versus-radical-resection-in-locally-advanced-rectal-cancer
#39
JOURNAL ARTICLE
Georg W Wurschi, Alexander Rühle, Justus Domschikowski, Maike Trommer, Simone Ferdinandus, Jan-Niklas Becker, Simon Boeke, Mathias Sonnhoff, Christoph A Fink, Lukas Käsmann, Melanie Schneider, Elodie Bockelmann, David Krug, Nils H Nicolay, Alexander Fabian, Klaus Pietschmann
Total neoadjuvant therapy (TNT) is an evolving treatment schedule for locally advanced rectal cancer (LARC), allowing for organ preservation in a relevant number of patients in the case of complete response. Patients who undergo this so-called "watch and wait" approach are likely to benefit regarding their quality of life (QoL), especially if definitive ostomy could be avoided. In this work, we performed the first cost-effectiveness analysis from the patient perspective to compare costs for TNT with radical resection after neoadjuvant chemoradiation (CRT) in the German health care system...
March 26, 2024: Cancers
https://read.qxmd.com/read/38610883/how-to-manage-beta-blockade-in-older-heart-failure-patients-a-scoping-review
#40
REVIEW
Iris Parrini, Fabiana Lucà, Carmelo Massimiliano Rao, Stefano Cacciatore, Carmine Riccio, Massimo Grimaldi, Michele Massimo Gulizia, Fabrizio Oliva, Felicita Andreotti
Beta blockers (BBs) play a crucial role in enhancing the quality of life and extending the survival of patients with heart failure and reduced ejection fraction (HFrEF). Initiating the therapy at low doses and gradually titrating the dose upwards is recommended to ensure therapeutic efficacy while mitigating potential adverse effects. Vigilant monitoring for signs of drug intolerance is necessary, with dose adjustments as required. The management of older HF patients requires a case-centered approach, taking into account individual comorbidities, functional status, and frailty...
April 5, 2024: Journal of Clinical Medicine
keyword
keyword
18154
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.